Sarepta Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 11.02 M | $1.38 B | 100.00% | 11.56% |
| VANGUARD GROUP INC | 11/13/2024 | 8.97 M | $1.12 B | -0.75% | 9.40% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 6.26 M | $781.72 M | 44.86% | 6.56% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.36 M | $544.41 M | 14.24% | 4.57% |
| STATE STREET CORP | 11/14/2024 | 4.27 M | $533.38 M | 3.11% | 4.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 2.73 M | $340.53 M | 32.26% | 2.86% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.58 M | $322.22 M | 12.42% | 2.70% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 2.56 M | $319.16 M | -14.81% | 2.68% |
| JPMORGAN CHASE & CO | 12/26/2024 | 2.20 M | $274.62 M | 19.26% | 2.31% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 2.12 M | $264.63 M | -0.55% | 2.22% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 1.95 M | $243.07 M | -0.63% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.70 M | $211.91 M | 2.68% | 1.78% |
| GROUPAMA ASSET MANAGMENT | 11/15/2024 | 1.30 M | $1.19 B | 100.00% | 1.36% |
| FMR LLC | 11/13/2024 | 1.24 M | $154.33 M | -33.58% | 1.30% |
| CASDIN CAPITAL, LLC | 11/14/2024 | 1.07 M | $134.07 M | 0.00% | 1.13% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.05 M | $131.20 M | 9.80% | 1.10% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 954,500 | $119.21 M | 47.76% | 1.00% |
| MORGAN STANLEY | 11/14/2024 | 953,104 | $119.03 M | -63.67% | 1.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 926,219 | $115.68 M | 19.39% | 0.97% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 783,029 | $97.79 M | 8.54% | 0.82% |
| CAMBER CAPITAL MANAGEMENT LP | 11/14/2024 | 775,000 | $96.79 M | 416.67% | 0.81% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 753,845 | $94.15 M | 9.19% | 0.79% |
| NORTHERN TRUST CORP | 11/13/2024 | 655,637 | $81.88 M | -1.86% | 0.69% |
| BOXER CAPITAL, LLC | 11/14/2024 | 650,000 | $81.18 M | 0.00% | 0.68% |
| 11/14/2024 | 636,065 | $79.43 M | 21.99% | 0.67% | |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 633,845 | $79.16 M | 13.42% | 0.66% |
| THRIVENT FINANCIAL FOR LUTHERANS | 11/07/2024 | 624,888 | $78.04 M | -3.07% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 611,749 | $76.40 M | 1.16% | 0.64% |
| ROYAL BANK OF CANADA | 11/14/2024 | 585,989 | $73.18 M | 18.25% | 0.61% |
| TWIN TREE MANAGEMENT, LP | 11/13/2024 | 583,500 | $72.87 M | 45.66% | 0.61% |
| INVESCO LTD. | 11/12/2024 | 482,161 | $60.22 M | 26.76% | 0.51% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 474,200 | $59.22 M | -1.87% | 0.50% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 464,916 | $58.06 M | 356.18% | 0.49% |
| BARCLAYS PLC | 11/19/2024 | 459,900 | $57.44 M | 14.72% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 436,600 | $54.53 M | -27.38% | 0.46% |
| ABRDN PLC | 10/25/2024 | 431,098 | $53.93 M | 30.70% | 0.45% |
| MIZUHO MARKETS AMERICAS LLC | 11/06/2024 | 399,065 | $49.84 M | 22.30% | 0.42% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 371,435 | $45.17 M | -8.52% | 0.39% |
| BRAIDWELL LP | 11/14/2024 | 370,400 | $46.26 M | 352.26% | 0.39% |
| UBS GROUP AG | 11/14/2024 | 364,172 | $45.48 M | 3.82% | 0.38% |
| FIERA CAPITAL CORP | 11/01/2024 | 359,996 | $44.96 M | -5.92% | 0.38% |
| AMUNDI | 11/13/2024 | 357,919 | $42.85 M | 7.50% | 0.38% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 350,052 | $43.72 M | -2.68% | 0.37% |
| BELLEVUE GROUP AG | 11/14/2024 | 344,348 | $43.01 M | 36.47% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 329,000 | $41.09 M | -54.36% | 0.34% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 324,332 | $40.51 M | -39.14% | 0.34% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 317,301 | $39.63 M | 2.88% | 0.33% |
| MAN GROUP PLC | 11/14/2024 | 311,338 | $38.88 M | -19.43% | 0.33% |
| CITADEL ADVISORS LLC | 11/14/2024 | 308,000 | $38.47 M | -20.23% | 0.32% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 307,500 | $38.40 M | 8.27% | 0.32% |
Sarepta Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 609 institutional investors and hedge funds held shares of Sarepta Therapeutics, Inc.. The most heavily invested institutionals were:
Fifth Third Wealth Advisors LLC: 0
DiNuzzo Private Wealth, Inc.: 0
Connective Portfolio Management, LLC: 0
TRUST CO OF VERMONT: 0
TSFG, LLC: 0
NBC SECURITIES, INC.: 0
91.42% of Sarepta Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 105.11 M shares in the last 24 months. This purchase volume represents approximately $12.24 B in transactions.